| Filed On | Filing |
|---|---|
| 19 Nov 2024 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +8 more
Section 1. Registered Office. The registered office of R1 RCM Inc. (hereinafter, the “Corporation”) in the State of Delaware shall be located at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, in the County of N... |
| 14 Nov 2024 |
8-K: Submission of Matters to a Vote of Security Holders
As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Raven Acquisition Holdings, LLC, a Delaware limited liability comp... |
| 05 Nov 2024 |
8-K: Results of Operations and Financial Condition
Murray, Utah - November 5, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announc... |
| 22 Oct 2024 |
8-K: Results of Operations and Financial Condition
As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Proje... |
| 04 Oct 2024 |
8-K: Regulation FD Disclosure
As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Proje... |
| 16 Sep 2024 |
8-K: Other Events
As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Raven Acquisition Holdings, LLC, a Delaware limited liability comp... |
| 07 Aug 2024 |
8-K: Results of Operations and Financial Condition
Murray, Utah - August 7, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced... |
| 01 Aug 2024 |
8-K: Entry into a Material Definitive Agreement; Other Events
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 31, 2024, by and among Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), Project Raven Merger Sub, Inc., a Delaware ... |
| 22 May 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
This Fifth Amended and Restated 2010 Stock Incentive Plan (the “Plan”) of R1 RCM Inc., a Delaware corporation formerly known as Accretive Health, Inc. (the “Company”), is effective as of April 8, 2024 (the “Effective Date”), and amends a... |
| 08 May 2024 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Murray, Utah - May 8, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physicia... |
| 19 Mar 2024 |
8-K: Other Events
As previously disclosed on March 11, 2024, the Board of Directors of R1 RCM Inc. (the “Company”) formed a special committee comprised solely of independent directors (the “Special Committee”), to evaluate all strategic alternatives in re... |
| 27 Feb 2024 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Murray, Utah - February 27, 2024 - R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and ph... |
| 15 Feb 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 15, 2024, the Board of Directors (the “Board”) of R1 RCM Inc. (the “Company”) appointed Pamela L. Spikner as principal accounting officer of the Company, effective immediately. Ms. Spikner’s appointment follows Mr. Evans’ not... |
| 06 Feb 2024 |
8-K: Entry into a Material Definitive Agreement
This Amendment No. 1 to Investor Rights Agreement, dated as of February 5, 2024 (this "Amendment"), is entered into by and among R1 RCM Inc., a Delaware corporation (the "Company"), CoyCo 1, L.P., a Delaware limited partnership ("Coyco 1... |
| 17 Jan 2024 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +4 more
This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of January 17, 2024, to the Second Amended and Restated Credit Agreement, dated as of June 21, 2022 (as amended by that certain Amendment No... |
| 08 Jan 2024 |
8-K: Results of Operations and Financial Condition
MURRAY, UT – January 8, 2024 – R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced preliminary fourt... |
| 19 Dec 2023 |
8-K: Departure/Election of Directors or Officers; Compensation
On December 18, 2023, the Board of Directors (the “Board”) of R1 RCM Inc. (the “Company”) appointed Clay Ashdown as a director of the Company, effective as of December 18, 2023, to serve until the Company’s 2024 Annual Meeting of Stockho... |
| 06 Dec 2023 |
8-K: Unregistered Sales of Equity Securities; Regulation FD Disclosure +1 more
R1 RCM to Acquire Acclara Acquisition of Providence’s Current Modular Services Business Accompanied by 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services |
| 17 Nov 2023 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
MURRAY, UT – November 17, 2023 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that, as anticipated,... |
| 13 Nov 2023 |
8-K: Non-Reliance on Previously Issued Financial Statements; Regulation FD Disclosure
R1 RCM to Restate Certain Previously Issued Financial Statements Due to Errors in Accounting for Expenses Associated with Historical Acquisitions |
Loading...